nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketobemidone—CYP2C8—Paclitaxel—ovarian cancer	0.201	0.212	CbGbCtD
Ketobemidone—CYP3A4—Topotecan—ovarian cancer	0.165	0.173	CbGbCtD
Ketobemidone—CYP2B6—Doxorubicin—ovarian cancer	0.143	0.151	CbGbCtD
Ketobemidone—CYP2C9—Paclitaxel—ovarian cancer	0.14	0.148	CbGbCtD
Ketobemidone—CYP3A4—Vinorelbine—ovarian cancer	0.116	0.122	CbGbCtD
Ketobemidone—CYP3A4—Paclitaxel—ovarian cancer	0.0815	0.0859	CbGbCtD
Ketobemidone—CYP3A4—Docetaxel—ovarian cancer	0.0589	0.0621	CbGbCtD
Ketobemidone—CYP3A4—Doxorubicin—ovarian cancer	0.0439	0.0463	CbGbCtD
Ketobemidone—OPRK1—Signaling by GPCR—PIK3CB—ovarian cancer	2.78e-05	0.000548	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PPP2R1A—ovarian cancer	2.71e-05	0.000534	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PPP2R1A—ovarian cancer	2.7e-05	0.000532	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—PIK3CD—ovarian cancer	2.7e-05	0.000532	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.69e-05	0.00053	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CAV1—ovarian cancer	2.69e-05	0.000529	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—CXCL8—ovarian cancer	2.67e-05	0.000527	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—YAP1—ovarian cancer	2.65e-05	0.000522	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.62e-05	0.000517	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—PIK3CB—ovarian cancer	2.59e-05	0.00051	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—ESR1—ovarian cancer	2.59e-05	0.00051	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.57e-05	0.000506	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—IL2—ovarian cancer	2.56e-05	0.000504	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—FASN—ovarian cancer	2.55e-05	0.000503	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—TERT—ovarian cancer	2.55e-05	0.000502	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—IL6ST—ovarian cancer	2.55e-05	0.000502	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—SLC5A5—ovarian cancer	2.51e-05	0.000495	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—ABCB1—ovarian cancer	2.51e-05	0.000494	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—CXCL8—ovarian cancer	2.49e-05	0.000491	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—TYMS—ovarian cancer	2.46e-05	0.000485	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—PIK3CG—ovarian cancer	2.45e-05	0.000482	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—APC—ovarian cancer	2.45e-05	0.000482	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—NRAS—ovarian cancer	2.45e-05	0.000482	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—CAV1—ovarian cancer	2.43e-05	0.00048	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CYTB—ovarian cancer	2.43e-05	0.000478	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—SLC2A1—ovarian cancer	2.42e-05	0.000478	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—IL2—ovarian cancer	2.38e-05	0.000469	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—YAP1—ovarian cancer	2.36e-05	0.000466	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CAV1—ovarian cancer	2.36e-05	0.000464	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—PIK3CB—ovarian cancer	2.35e-05	0.000464	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—MAPK3—ovarian cancer	2.34e-05	0.000462	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.34e-05	0.000462	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.34e-05	0.000461	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.33e-05	0.000458	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CYP1B1—ovarian cancer	2.32e-05	0.000458	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.31e-05	0.000454	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—ESR1—ovarian cancer	2.27e-05	0.000447	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—CXCL8—ovarian cancer	2.26e-05	0.000445	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—IL6ST—ovarian cancer	2.23e-05	0.00044	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—MAPK1—ovarian cancer	2.23e-05	0.000439	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—EGFR—ovarian cancer	2.23e-05	0.000439	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PIK3CG—ovarian cancer	2.22e-05	0.000437	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—IL2—ovarian cancer	2.16e-05	0.000426	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—FASN—ovarian cancer	2.16e-05	0.000426	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—YAP1—ovarian cancer	2.16e-05	0.000425	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—TERT—ovarian cancer	2.15e-05	0.000424	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—PIK3CD—ovarian cancer	2.15e-05	0.000424	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—APC—ovarian cancer	2.15e-05	0.000423	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PIK3CG—ovarian cancer	2.15e-05	0.000423	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—NRAS—ovarian cancer	2.15e-05	0.000423	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.13e-05	0.000421	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—PIK3CA—ovarian cancer	2.13e-05	0.00042	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—SLC5A5—ovarian cancer	2.12e-05	0.000419	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PPP1CC—ovarian cancer	2.12e-05	0.000418	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—BRIP1—ovarian cancer	2.12e-05	0.000418	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—KRAS—ovarian cancer	2.11e-05	0.000415	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PPP2R1A—ovarian cancer	2.06e-05	0.000406	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.06e-05	0.000405	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—MAPK3—ovarian cancer	2.05e-05	0.000405	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—SLC2A1—ovarian cancer	2.05e-05	0.000404	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.01e-05	0.000396	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CAV1—ovarian cancer	1.99e-05	0.000392	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—CAV1—ovarian cancer	1.98e-05	0.000391	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CYP1B1—ovarian cancer	1.97e-05	0.000388	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—MAPK1—ovarian cancer	1.96e-05	0.000385	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—EGFR—ovarian cancer	1.95e-05	0.000385	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PIK3CD—ovarian cancer	1.95e-05	0.000384	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—PIK3CA—ovarian cancer	1.93e-05	0.000381	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—FASN—ovarian cancer	1.93e-05	0.00038	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—ESR1—ovarian cancer	1.92e-05	0.000378	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—ABCB1—ovarian cancer	1.91e-05	0.000377	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—ERBB2—ovarian cancer	1.9e-05	0.000374	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—SLC5A5—ovarian cancer	1.9e-05	0.000374	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.9e-05	0.000374	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—IL6ST—ovarian cancer	1.89e-05	0.000372	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PIK3CD—ovarian cancer	1.89e-05	0.000372	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—TYMS—ovarian cancer	1.88e-05	0.00037	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.88e-05	0.00037	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—MTOR—ovarian cancer	1.87e-05	0.000369	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—PIK3CB—ovarian cancer	1.87e-05	0.000369	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—PIK3CA—ovarian cancer	1.87e-05	0.000368	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—KRAS—ovarian cancer	1.85e-05	0.000364	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—SLC2A1—ovarian cancer	1.83e-05	0.000361	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PIK3CG—ovarian cancer	1.81e-05	0.000357	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—APC—ovarian cancer	1.81e-05	0.000357	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—NRAS—ovarian cancer	1.81e-05	0.000357	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PIK3CG—ovarian cancer	1.81e-05	0.000356	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CXCL8—ovarian cancer	1.8e-05	0.000355	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.79e-05	0.000353	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—HRAS—ovarian cancer	1.79e-05	0.000353	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CDKN1B—ovarian cancer	1.76e-05	0.000347	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—FASN—ovarian cancer	1.76e-05	0.000346	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CYP1B1—ovarian cancer	1.76e-05	0.000346	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	1.74e-05	0.000344	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—AKT1—ovarian cancer	1.74e-05	0.000343	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—MAPK3—ovarian cancer	1.74e-05	0.000342	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.74e-05	0.000342	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—SLC5A5—ovarian cancer	1.73e-05	0.000341	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CASP3—ovarian cancer	1.72e-05	0.00034	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—IL2—ovarian cancer	1.72e-05	0.000339	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—IL6—ovarian cancer	1.71e-05	0.000338	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PIK3CB—ovarian cancer	1.7e-05	0.000335	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—PIK3CA—ovarian cancer	1.7e-05	0.000334	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CCND1—ovarian cancer	1.68e-05	0.000331	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—SLC2A1—ovarian cancer	1.67e-05	0.000329	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—ERBB2—ovarian cancer	1.67e-05	0.000328	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CTNNB1—ovarian cancer	1.66e-05	0.000328	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—MAPK1—ovarian cancer	1.65e-05	0.000326	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—EGFR—ovarian cancer	1.65e-05	0.000326	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—MTOR—ovarian cancer	1.64e-05	0.000324	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PIK3CB—ovarian cancer	1.64e-05	0.000324	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.64e-05	0.000322	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—MMP9—ovarian cancer	1.63e-05	0.000321	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—PTEN—ovarian cancer	1.62e-05	0.000319	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—ABCB1—ovarian cancer	1.62e-05	0.000319	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CYP1B1—ovarian cancer	1.6e-05	0.000316	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PIK3CD—ovarian cancer	1.59e-05	0.000314	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—TYMS—ovarian cancer	1.59e-05	0.000314	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PIK3CD—ovarian cancer	1.59e-05	0.000313	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—AKT1—ovarian cancer	1.58e-05	0.000311	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CXCL8—ovarian cancer	1.58e-05	0.000311	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—PIK3CA—ovarian cancer	1.58e-05	0.000311	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—HRAS—ovarian cancer	1.57e-05	0.000309	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—KRAS—ovarian cancer	1.56e-05	0.000308	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	1.56e-05	0.000307	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.55e-05	0.000305	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CDKN1B—ovarian cancer	1.54e-05	0.000304	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—AKT1—ovarian cancer	1.53e-05	0.000301	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CAV1—ovarian cancer	1.51e-05	0.000298	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CASP3—ovarian cancer	1.51e-05	0.000298	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—IL2—ovarian cancer	1.51e-05	0.000298	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—IL6—ovarian cancer	1.5e-05	0.000296	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CCND1—ovarian cancer	1.47e-05	0.00029	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PTEN—ovarian cancer	1.47e-05	0.000289	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—VEGFA—ovarian cancer	1.46e-05	0.000288	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CTNNB1—ovarian cancer	1.46e-05	0.000287	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—STAT3—ovarian cancer	1.45e-05	0.000286	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—ABCB1—ovarian cancer	1.45e-05	0.000285	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—NRAS—ovarian cancer	1.45e-05	0.000285	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—PIK3CA—ovarian cancer	1.43e-05	0.000283	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—MMP9—ovarian cancer	1.43e-05	0.000282	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—YAP1—ovarian cancer	1.42e-05	0.00028	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PTEN—ovarian cancer	1.42e-05	0.00028	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—TYMS—ovarian cancer	1.42e-05	0.00028	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	1.42e-05	0.00028	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.41e-05	0.000278	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—ERBB2—ovarian cancer	1.41e-05	0.000277	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PIK3CB—ovarian cancer	1.39e-05	0.000274	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—MTOR—ovarian cancer	1.39e-05	0.000274	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—AKT1—ovarian cancer	1.39e-05	0.000273	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PIK3CB—ovarian cancer	1.39e-05	0.000273	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—MAPK3—ovarian cancer	1.38e-05	0.000273	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PIK3CG—ovarian cancer	1.38e-05	0.000272	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—MYC—ovarian cancer	1.35e-05	0.000265	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CXCL8—ovarian cancer	1.34e-05	0.000263	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—HRAS—ovarian cancer	1.33e-05	0.000261	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—ABCB1—ovarian cancer	1.32e-05	0.00026	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—MAPK1—ovarian cancer	1.32e-05	0.00026	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—EGFR—ovarian cancer	1.32e-05	0.00026	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CDKN1B—ovarian cancer	1.3e-05	0.000257	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—TYMS—ovarian cancer	1.29e-05	0.000255	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—AKT1—ovarian cancer	1.29e-05	0.000254	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—VEGFA—ovarian cancer	1.28e-05	0.000253	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CAV1—ovarian cancer	1.28e-05	0.000253	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CASP3—ovarian cancer	1.28e-05	0.000252	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—IL2—ovarian cancer	1.28e-05	0.000251	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—STAT3—ovarian cancer	1.27e-05	0.00025	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—IL6—ovarian cancer	1.27e-05	0.00025	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—NRAS—ovarian cancer	1.27e-05	0.00025	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—KRAS—ovarian cancer	1.24e-05	0.000245	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CCND1—ovarian cancer	1.24e-05	0.000245	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CTNNB1—ovarian cancer	1.23e-05	0.000243	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.22e-05	0.000241	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—MAPK3—ovarian cancer	1.21e-05	0.000239	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PIK3CD—ovarian cancer	1.21e-05	0.000239	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—MMP9—ovarian cancer	1.21e-05	0.000238	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PTEN—ovarian cancer	1.2e-05	0.000237	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PTEN—ovarian cancer	1.2e-05	0.000236	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—MYC—ovarian cancer	1.18e-05	0.000233	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—AKT1—ovarian cancer	1.17e-05	0.000231	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PIK3CG—ovarian cancer	1.17e-05	0.00023	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—FASN—ovarian cancer	1.16e-05	0.000228	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—MAPK1—ovarian cancer	1.15e-05	0.000228	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—EGFR—ovarian cancer	1.15e-05	0.000228	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CAV1—ovarian cancer	1.14e-05	0.000226	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—PIK3CA—ovarian cancer	1.14e-05	0.000225	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—SLC5A5—ovarian cancer	1.14e-05	0.000225	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—TP53—ovarian cancer	1.11e-05	0.000218	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—SLC2A1—ovarian cancer	1.1e-05	0.000217	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.09e-05	0.000215	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—KRAS—ovarian cancer	1.09e-05	0.000215	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—VEGFA—ovarian cancer	1.08e-05	0.000214	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—STAT3—ovarian cancer	1.07e-05	0.000212	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—NRAS—ovarian cancer	1.07e-05	0.000211	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—HRAS—ovarian cancer	1.06e-05	0.000208	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PIK3CB—ovarian cancer	1.06e-05	0.000208	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CYP1B1—ovarian cancer	1.06e-05	0.000208	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CAV1—ovarian cancer	1.04e-05	0.000206	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PIK3CG—ovarian cancer	1.04e-05	0.000205	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PIK3CA—ovarian cancer	1.04e-05	0.000204	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PIK3CD—ovarian cancer	1.03e-05	0.000202	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—MAPK3—ovarian cancer	1.03e-05	0.000202	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—IL6—ovarian cancer	1.01e-05	0.000199	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PIK3CA—ovarian cancer	1e-05	0.000198	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—MYC—ovarian cancer	9.98e-06	0.000197	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	9.97e-06	0.000196	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—MAPK1—ovarian cancer	9.76e-06	0.000192	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—EGFR—ovarian cancer	9.76e-06	0.000192	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—TP53—ovarian cancer	9.7e-06	0.000191	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PIK3CG—ovarian cancer	9.5e-06	0.000187	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	9.36e-06	0.000185	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—AKT1—ovarian cancer	9.34e-06	0.000184	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—HRAS—ovarian cancer	9.27e-06	0.000183	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—KRAS—ovarian cancer	9.22e-06	0.000182	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PIK3CD—ovarian cancer	9.16e-06	0.000181	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PTEN—ovarian cancer	9.13e-06	0.00018	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PIK3CB—ovarian cancer	8.95e-06	0.000176	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—IL6—ovarian cancer	8.87e-06	0.000175	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ABCB1—ovarian cancer	8.7e-06	0.000171	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—TYMS—ovarian cancer	8.54e-06	0.000168	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PIK3CA—ovarian cancer	8.47e-06	0.000167	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—AKT1—ovarian cancer	8.46e-06	0.000167	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PIK3CA—ovarian cancer	8.44e-06	0.000166	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PIK3CD—ovarian cancer	8.35e-06	0.000165	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—TP53—ovarian cancer	8.19e-06	0.000161	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—AKT1—ovarian cancer	8.19e-06	0.000161	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PIK3CB—ovarian cancer	7.99e-06	0.000157	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—HRAS—ovarian cancer	7.84e-06	0.000154	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PTEN—ovarian cancer	7.73e-06	0.000152	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—IL6—ovarian cancer	7.5e-06	0.000148	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PIK3CB—ovarian cancer	7.28e-06	0.000144	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—AKT1—ovarian cancer	6.92e-06	0.000136	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PTEN—ovarian cancer	6.9e-06	0.000136	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—AKT1—ovarian cancer	6.9e-06	0.000136	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CAV1—ovarian cancer	6.88e-06	0.000136	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PIK3CA—ovarian cancer	6.44e-06	0.000127	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PTEN—ovarian cancer	6.29e-06	0.000124	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PIK3CG—ovarian cancer	6.27e-06	0.000124	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PIK3CD—ovarian cancer	5.51e-06	0.000109	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PIK3CA—ovarian cancer	5.45e-06	0.000107	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—AKT1—ovarian cancer	5.26e-06	0.000104	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PIK3CA—ovarian cancer	4.87e-06	9.59e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PIK3CB—ovarian cancer	4.8e-06	9.46e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—AKT1—ovarian cancer	4.46e-06	8.78e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PIK3CA—ovarian cancer	4.44e-06	8.75e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PTEN—ovarian cancer	4.15e-06	8.18e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—AKT1—ovarian cancer	3.98e-06	7.84e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—AKT1—ovarian cancer	3.63e-06	7.15e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PIK3CA—ovarian cancer	2.93e-06	5.77e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—AKT1—ovarian cancer	2.39e-06	4.71e-05	CbGpPWpGaD
